SVWAG
JAZZ icon

Sound View Wealth Advisors Group’s Jazz Pharmaceuticals JAZZ Stock Holding History

Sound View Wealth Advisors Group’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.68M Buy
8,898
+102
+1% +$17.8K 0.11% 140
2025
Q4 		$1.5M Sell
8,796
-501
-5% -$76.8K 0.1% 151
2025
Q3 		$1.23M Buy
9,297
+164
+2% +$19.7K 0.08% 178
2025
Q2 		$969K Buy
9,133
+708
+8% +$76.9K 0.07% 190
2025
Q1 		$1.05M Buy
8,425
+110
+1% +$14.3K 0.09% 168
2024
Q4 		$1.02M Buy
8,315
+206
+3% +$24.3K 0.08% 172
2024
Q3 		$903K Buy
8,109
+1,422
+21% +$156K 0.07% 191
2024
Q2 		$714K Buy
6,687
+2,100
+46% +$231K 0.07% 195
2024
Q1 		$552K Buy
4,587
+167
+4% +$20.5K 0.06% 227
2023
Q4 		$544K Buy
4,420
+702
+19% +$87.6K 0.06% 225
2023
Q3 		$481K Buy
3,718
+648
+21% +$86.3K 0.06% 224
2023
Q2 		$381K Buy
+3,070
New +$413K 0.05% 257
2023
Q1 		– Sell
-4,420
Closed -$544K – 389
2022
Q4 		$544K Buy
+4,420
New +$648K 0.06% 225

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Sound View Wealth Advisors Group's JAZZ Position: Q1 2026 in Review

Sound View Wealth Advisors Group increased its Jazz Pharmaceuticals (JAZZ) stake by 1.2% in Q1 2026, buying an estimated $17.8K and bringing the position to 8,898 shares worth $1.68M. The position accounts for 0.11% of the portfolio, ranked #140.

Sound View Wealth Advisors Group first reported a position in JAZZ in Q4 2022 and has held it in 13 quarters since. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Sound View Wealth Advisors Group held 8,898 shares of Jazz Pharmaceuticals worth $1.68M as of Q1 2026.
  • Sound View Wealth Advisors Group bought 102 Jazz Pharmaceuticals shares in Q1 2026, an estimated $17.8K.
  • Jazz Pharmaceuticals made up 0.11% of Sound View Wealth Advisors Group's portfolio in Q1 2026, its #140 holding.
  • Sound View Wealth Advisors Group first reported a position in Jazz Pharmaceuticals in Q4 2022 and has held it in 13 quarters since.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Sound View Wealth Advisors Group's 13F filing for Q1 2026, filed 6 May 2026.